Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-04-19

CHEMICAL COMPOSITION AND STRUCTURE OF FOOD CONSTITUENTS : DEFINING ALLERGENIC POTENTIAL

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Wyniki nadające się do wykorzystania

Food allergies affect a significant proportion of the population with consequent adverse effects. Food allergies are due not to the whole protein but to a discrete area (peptide) and especially to the reactive sequence (epitope) of amino acids in the peptide. Molecular biology techniques are being used to identify or synthesise the peptide sequences and this information will be used to develop a strategy for making 'allergen-free' food products as well as developing improved immunoassays for the investigation of allergenic reactions. Allergens encourage the production of immunoglobulin E (IgE) antibodies which bind the allergen and trigger the allergic cascade. Experiments have been designed where food allergens will be screened for their ability to induce immune responses, not directly in the body, but in in-vitro culture systems of human lymph cells. This should lead to improved understanding of the mechanism of food allergy thus helping to protect the consumer. Studies have been initiated using a milk protein (beta-lactoglobulin) as the model compound, as its molecular structure has been well documented. For example, a procedure has been developed to isolate `gram' quantities of homogenous beta-lactoglobulin. This preparation is used for the production of beta-lactoglobulin hydrolysates to be tested by screening with human sera as well as in experimental animal studies. A new and improved test procedure has been developed in order to determine that region of the peptide preferentially recognized by IgE antibodies present in sera obtained from cow's milk allergic patients. This test will become a most useful tool in the development of the project. An experimental animal model which provides specific beta-lactoglobulin IgE antibodies has been established using the Brown Norway rat, and is available for screening milk hydrolysates and peptides.

Wyszukiwanie danych OpenAIRE...

Podczas wyszukiwania danych OpenAIRE wystąpił błąd

Brak wyników

Moja broszura 0 0